Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
YiChang HEC ChangJiang Pharmaceutical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

$9.4

2024-06-28

Market Capitalization

$8.3 B

2024-06-28

Revenue

¥6.3 B

FY, 2023

CreditSafe Score

?
Score changed on Jul 15, 2024
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

CNYFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022FY, 2023
Revenue2.5B6.2B2.3B913.8M3.7B6.3B
Cost of goods sold110.5M650.5M351.5M430.1M519.9M916.7M
Gross profit2.4B5.6B2.3B549.1M3.2B5.4B
Gross profit margin, %95.9%89.7%96.4%60.1%86.6%85.4%
Operating expense total1.3B3.0B1.4B699.3M1.7B2.1B
Depreciation and amortization64.2M108.7M153.3M316.6M667.8M877.5M
EBITDA1.1B2.5B851.3M(150.2M)1.6B3.3B
EBITDA margin, %45.6%40.9%36.3%-16.4%41.6%51.7%
EBIT1.1B2.4B692.8M(489.0M)888.6M2.4B
EBIT margin, %43.1%39.2%29.5%-53.5%23.7%38.0%
Interest income14.6M36.0M25.0M11.3M6.7M57.8M
Interest expense1.4M204.5M244.2M243.8M281.6M227.4M
Pre tax profit1.1B2.3B1.0B(667.2M)39.4M2.1B
Income tax expense201.1M361.9M173.0M(79.5M)(9.8M)270.9M
Net Income901.2M1.9B837.4M(587.7M)49.2M1.9B

Footer menu